MedTech News
Molecular test helps tailor chemotherapy for advanced prostate cancer patients
Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit from unpleasant side effects, according to a new study led by UCL researchers.
AI and lab tests combine to predict disease risk from rare genetic variants
When genetic testing reveals a rare DNA mutation, doctors and patients are frequently left in the dark about what it actually means. Now, researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful new way to determine whether a patient with a mutation is likely to actually develop disease, a concept known in genetics as penetrance.
Novel blood test for ALS can detect early signs years before symptoms appear
Current ALS diagnosis relies on neurological evaluations and the presence of symptoms; at present, there is no definitive diagnostic test.
Blood pressure calculator promises more precise medication choices for millions
A first-of-its-kind Blood Pressure Treatment Efficacy Calculator built on data from nearly 500 randomized clinical trials in over 100,000 people allows doctors to see how much different medications are likely to lower blood pressure.
MIT researchers develop AI tool to improve flu vaccine strain selection
VaxSeer uses machine learning to predict virus evolution and antigenicity, aiming to make vaccine selection more accurate and less reliant on guesswork.
Blood test able to detect ALS up to a decade before symptoms start
Current ALS diagnosis relies on neurological evaluations and the presence of symptoms, with no definitive diagnostic test currently available.
Medtronic Evolut wins FDA nod for expanded redo TAVR indication
Medtronic (NYSE: MDT)+
announced today that it received FDA approval for the expanded redo-TAVR indication of its Evolut system.
SEOULTECH Researchers Develop Smarter, More Controllable Hydrogel Pores
In a recent study, researchers introduced an origami-inspired “facet-driven folding” strategy using polygonal hydrogel pores to deliver highly controlled, programmable actuation, opening new possibilities for selective drug delivery and information encryption.